MEFENAMIC ACID

PRODUCT IDENTIFICATION

CAS NO. 61-68-7

MEFENAMIC ACID

EINECS NO. 200-513-1
FORMULA C15H15NO2
MOL WT. 241.29

H.S. CODE

2922.49

TOXICITY

 

SYNONYMS Forte Mefenamic acid; Ponstan; Mefenaminsaeure;
2-[(2,3-Dimethylphenyl)amino]benzoic acid; Mefic; Ponstel; N-(2,3-Xylyl)anthranilic acid; N-(2,3-Dimethylphenyl)anthranilic acid; N-(2,3-Xylyl)-2-aminobenzoic acid; 2',3'-dimethyl-2-Diphenylaminecarboxylic acid; 2',3'-dimethyl-N-phenyl-anthranilic acid; Mefenamsäure (Dutch); ácido mefenamico (Spanish); Acide mefenamique (French);
PRICE

U$14.-/kg (1,000kgs)

CLASSIFICATION

 

PHYSICAL AND CHEMICAL PROPERTIES

PHYSICAL STATE White to light yellow crystalline powder
MELTING POINT 229 C
BOILING POINT

 

SPECIFIC GRAVITY

 

SOLUBILITY IN WATER insoluble
pH  
VAPOR DENSITY

 

AUTOIGNITION

 

NFPA RATINGS

 

REFRACTIVE INDEX

 

FLASH POINT

 

STABILITY

Stable under ordinary conditions

APPLICATIONS

Mefenamic Acid is a drug belong to a class of NSAID (nonsteroidal anti-inflammatory drug) acts by inhibiting isoforms of cyclo-oxygenase 1 and 2. It has an activity to treat inflammatory  rheumatoid diseases and relieve acute pain. It is effective against period pains, pain after surgery, and fever.

 

Nonsteroidal Antiinflammatory Drugs (NSAIDs); chemically heterogeneous large groups of drugs which suppress inflammation in a manner similar to steroids, but less side effects of sedation, respiratory depression, or addiction than steroids. They are widely used for the treatment of inflammatory disorders and painful conditions such as rheumatoid arthritis, gout, bursitis, painful menstruation, and headache. They are effective in the relief of pain and fever. NSAIDs inhibit the cyclooxygenase (COX) activity resulting in decreased synthesis of prostaglandin, leukotriene and thromboxane precursors such as the ubiquitous enzyme which catalyzes the initial step in the synthesis of prostanoids. Prostanoid is any of a group of C-20 fatty acids complex with an internal five or six carbon rings such as prostaglandins, prostanoic acid, prostacyclins, and thromboxane; derived from arachidonic acid (C-20 polyunsaturated fatty acid with four cis double bonds). The action or the synthesis of prostanoids are involved in the modulation of a variety of pathophysiologic processes including inflammation, hemostasis, thrombosis, cytoprotection,  ulceration, hemodynamics and other the progression of kidney diseases. Thus, NSAIDs as non-selective inhibitors of the cyclooxygenases (both the cyclooxygenase-1 and cyclooxygenase-2 isoenzymes) may have beneficial as well as untoward effects on a variety of human diseases. Low stomach prostanoid levels caused by COX-1 inhibitors can result in ulceration and internal bleeding and perforation. The selective COX-2 inhibitors such as oxicam, meloxicam, and coxibs (celecoxib, rofecoxib, valdecoxib, parecoxib and etoricoxib) do not interfere with COX-1. The most prominent NSAID is aspirin. Nonaspirin NSAIDs can be classified based on chemical structures.

Nonsteroidal Anti-Inflammatory Drugs (NSAID) by chemical structure

  • Carboxylic Acid Groups
    • Salicylates (Acetylsalicylate, Choline salicylate, Diflunisal, Magnesium choline salicylate, Magnesium salicylate, Salsalate)
    • Acetic Acids (Bendazac, Diclofenac, Etodolac, Indomethacin, Ketorolac, Nabumetone, Sulindac, Tolmetin)
    • Propionic acids (Carprofen, Fenoprofen, Flurbiprofen, Ibuprofen, Ketoprofen, Loxoprofen, Naproxen, Naproxen sodium, Oxaprozin, Vedaprofen)
    • Anthranilic acids (Meclofenamic acid, Meclofenamate sodium, Tolfenamic acid)
    • Phenylacetic acids
    • Aminonicotinic acids (Flunixin)
    • Indole Analogs (Indomethacin, Nabumetone, Ketorolac, Etodolac,)
  • Enolic Acid Groups (which doesn't have carboxylic group but acid due to the enolic hydroxy substituent)
    • Pyrazolones (Phenylbutazone, Oxyphenbutazone, Dipyrone, Ramifenazone)
    • Oxicams (Meloxicam, Piroxicam, Tenoxicam)
  • Coxibs
    • Celecoxib, Rofecoxib, Valdecoxib, Parecoxib, Etoricoxib
  • Gold Salts
    • Auranofin, Gold sodium thiomalate, Aurothioglucose

SALES SPECIFICATION

BIBLIOGRAPHY

BP98

APPEARANCE

White to light yellow crystalline powder

ASSAY

99.0 - 100.5%

ASH

0.1% max

COPPER

10ppm max

HEAVY METALS

20ppm max

LOSS ON DRYING

0.5% max

TRANSPORTATION
PACKING

25kgs in fiber drum

HAZARD CLASS  
UN NO.  
PRICE

Click to open the table